BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28981535)

  • 1. Predictors of transitions in frailty severity and mortality among people aging with HIV.
    Brothers TD; Kirkland S; Theou O; Zona S; Malagoli A; Wallace LMK; Stentarelli C; Mussini C; Falutz J; Guaraldi G; Rockwood K
    PLoS One; 2017; 12(10):e0185352. PubMed ID: 28981535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity.
    Guaraldi G; Brothers TD; Zona S; Stentarelli C; Carli F; Malagoli A; Santoro A; Menozzi M; Mussi C; Mussini C; Kirkland S; Falutz J; Rockwood K
    AIDS; 2015 Aug; 29(13):1633-41. PubMed ID: 26372273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frailty transitions, inflammation, and mortality among persons aging with HIV infection and injection drug use.
    Piggott DA; Bandeen-Roche K; Mehta SH; Brown TT; Yang H; Walston JD; Leng SX; Kirk GD
    AIDS; 2020 Jul; 34(8):1217-1225. PubMed ID: 32287069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV.
    Guaraldi G; Zona S; Silva AR; Menozzi M; Dolci G; Milic J; Carli F; Mussini C
    PLoS One; 2019; 14(2):e0212283. PubMed ID: 30763363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of frailty phenotype and frailty index and their associations with clinical outcomes.
    Guaraldi G; Malagoli A; Theou O; Brothers TD; Wallace L; Torelli R; Mussini C; Sartini S; Kirkland SA; Rockwood K
    HIV Med; 2017 Nov; 18(10):764-771. PubMed ID: 28737297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief Report: Frailty in Aging People Living With HIV: A Matched Controlled Study.
    Lellouche L; Gutierrez LA; Leclercq P; Zaegel-Faucher O; Bernard L; Vassallo M; Barbuat C; Ozguler A; Zins M; Nailler L; Reynes J; Berr C; Makinson A
    J Acquir Immune Defic Syndr; 2021 Nov; 88(3):305-309. PubMed ID: 34238822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
    Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
    J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease.
    Ho JE; Scherzer R; Hecht FM; Maka K; Selby V; Martin JN; Ganz P; Deeks SG; Hsue PY
    AIDS; 2012 Jun; 26(9):1115-20. PubMed ID: 22382147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy.
    Collazos J; Valle-Garay E; Carton JA; Montes AH; Suarez-Zarracina T; De la Fuente B; Asensi V
    HIV Med; 2016 Aug; 17(7):532-41. PubMed ID: 26754349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study.
    Miller TL; Easley KA; Zhang W; Orav EJ; Bier DM; Luder E; Ting A; Shearer WT; Vargas JH; Lipshultz SE; ;
    Pediatrics; 2001 Dec; 108(6):1287-96. PubMed ID: 11731650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased ocular lens density in HIV-infected individuals with low nadir CD4 counts in South Africa: evidence of accelerated aging.
    Pathai S; Lawn SD; Weiss HA; Cook C; Bekker LG; Gilbert CE
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):307-14. PubMed ID: 23403862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals.
    Ho JE; Deeks SG; Hecht FM; Xie Y; Schnell A; Martin JN; Ganz P; Hsue PY
    AIDS; 2010 Jul; 24(12):1897-905. PubMed ID: 20543654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frailty, HIV infection, and mortality in an aging cohort of injection drug users.
    Piggott DA; Muzaale AD; Mehta SH; Brown TT; Patel KV; Leng SX; Kirk GD
    PLoS One; 2013; 8(1):e54910. PubMed ID: 23382997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource-limited setting.
    Brennan AT; Maskew M; Sanne I; Fox MP
    Trop Med Int Health; 2013 May; 18(5):619-31. PubMed ID: 23419157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in People Aging With HIV.
    Brañas F; Sánchez-Conde M; Carli F; Menozzi M; Raimondi A; Milic J; Franconi J; Cuomo G; Mussini C; Moreno S; Guaraldi G
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):284-291. PubMed ID: 32032279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score.
    Hentzien M; Delpierre C; Pugliese P; Allavena C; Jacomet C; Valantin MA; Cabié A; Cuzin L; Rey D; Bani-Sadr F; Dramé M;
    PLoS One; 2018; 13(4):e0195725. PubMed ID: 29672628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences for frailty in HIV-infected patients on stable antiretroviral therapy and with an undetectable viral load.
    Blanco JR; Barrio I; Ramalle-Gómara E; Beltran MI; Ibarra V; Metola L; Sanz M; Oteo JA; Melús E; Antón L
    PLoS One; 2019; 14(5):e0215764. PubMed ID: 31071105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resilience and Frailty in People Living With HIV During the COVID Era: Two Complementary Constructs Associated With Health-Related Quality of Life.
    Guaraldi G; Milic J; Barbieri S; Marchiò T; Caselgrandi A; Volpi S; Aprile E; Belli M; Venuta M; Mussini C
    J Acquir Immune Defic Syndr; 2022 Feb; 89(Suppl 1):S65-S72. PubMed ID: 35015747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment interruption of highly active antiretroviral therapy in patients with nadir CD4 cell counts >200 cells/mm3.
    Toulson AR; Harrigan R; Heath K; Yip B; Brumme ZL; Harris M; Hogg RS; Montaner JS
    J Infect Dis; 2005 Nov; 192(10):1787-93. PubMed ID: 16235178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frailty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use.
    Piggott DA; Varadhan R; Mehta SH; Brown TT; Li H; Walston JD; Leng SX; Kirk GD
    J Gerontol A Biol Sci Med Sci; 2015 Dec; 70(12):1542-7. PubMed ID: 26386010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.